Terumo to build new manufacturing facility in Japan
16 May 2023
Terumo announced that it plans to construct a new manufacturing facility for its Medical Care Solutions Company in Japan.
The company’s investment in the facility totals $382.9 million (¥52.2 billion). Terumo expects to complete construction in fiscal 2025. It’s located in the premises of the Kofu Factory in Yamanashi, Japan, according to a news release.
Once operations begin, the company plans to utilize the facility for its contract development and manufacturing organization (CDMO) business. It also plans to manufacture products related to peritoneal dialysis. Additionally, Terumo expects the facility to provide additional spaces to enable it to scale up production to meet future demand.
The Terumo CDMO business provides integrated support for drug-device combination products. This ranges from design to commercial manufacturing through partnerships with pharmaceutical companies. The company expanded its CDMO business globally over the past year or so, it said. It represents a pillar of its five-year growth strategy and Terumo said it wants to optimize production capacity.
TerumoTerumo also promotes peritoneal dialysis therapy by providing devices designed for easy use and the reduction of infection risk. Its dialysis solutions also reduce the burden on the patient’s body. The company aims to contribute to the improvement of the quality of peritoneal dialysis therapy. It also wants to meet the expected increase in product demand in this space.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.